FILTER

FILTERED INTERVIEW RESULTS

Mining
Ghana
MACIG

Regina Ofori-Twumasi

MANAGING CONSULTANT, ALFREG
Alfreg explains how it can help mining companies to establish in Ghana.
Mining
DRC
MACIG

Feni Matsando Samuel

CEO, INTER-ORIENTAL BUILDERS (IOB)
MACIG Copperbelt & Angola 2021
IOB is a Congolese contractor that looks to develop national skills with the mining industry
Mining
South Africa
Zambia
DRC
Mozambique
Namibia
Niger
Nigeria
Angola
MACIG

Shahram Tafazoli

FOUNDER AND CEO, MOTION METRICS
Motion Mertics explains how the latest technologies are being deployed in African mines.
Mining
Mali
MACIG

Alistair Cowden

EXECUTIVE CHAIRMAN, FIREFINCH
Firefinch is a West Australian goal company redeveloping the former Morila gold mine in Mali.
Mining
DRC
MACIG

Djo Moupondo

CEO, SODEICO
Sodeico explains how it can meet the challenges of providing a skilled workforce for mines in DRC.
Mining
Ghana
MACIG

Zoe Phillips Takyi - Appiah

SENIOR PARTNER, JLD AND MB LEGAL CONSULTANCY
JLD and MB Legal Consultancy comment on the current investment climate in Ghana’s extractive industries.
Mining
Nigeria
MACIG

Minister Arc. Olamilekan Adegbite

MINISTER OF MINES AND STEEL DEVELOPMENT, NIGERIA
MACIG West Africa 2020-2021
Nigeria’s Minister of Mines and Steel Development explains how the country is eagerly luring investors to its under-developed mining sector.
Mining
DRC
MACIG

Marie-Claire Yaya

CEO, ITM HOLDING
MACIG Copperbelt & Angola 2021
ITM Holding describes the services that it is bringing to DRC and intends to offer across Africa.
Mining
Burkina Faso
MACIG

Gordon Stothart

PRESIDENT AND CEO, IAMGOLD CORPORATION
IAMGOLD describes how organic growth will drive the company for the immediate future.
Mining
Mali
MACIG

Nana Bompeh Sangmuah

PRESIDENT AND CEO, ROSCAN GOLD
Roscan Gold describes progress at its Kandiolé project in Mali.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL